INVASIVE INTERVENTIONS IN STRUCTURAL HEART DISEASES: COMPREHENSIVE TECHNIQUES

Invasive Interventions in Structural Heart Diseases-kapak

LONG TERM OUTCOMES AND FOLLOW-UP OF PULMONARY VALVE INTERVENTIONAL PROCEDURES

Ufuk Yıldız

Başakşehir Çam ve Sakura City Hospital, Department of Cardiology, İstanbul, Türkiye

Yıldız U. Long Term Outcomes and Follow-Up of Pulmonary Valve Interventional Procedures. In: Tanık VO, Özlek B editors. Invasive Interventions in Structural Heart Diseases: Comprehensive Techniques. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.397-402.

ABSTRACT

Pulmonary valve interventional procedures have revolutionized the treatment of various pulmonary valve disorders, offering minimally invasive alternatives to traditional surgical approaches. Among these procedures, percutaneous balloon pulmonary valvuloplasty (PBPV), transcatheter pulmonary valve replacement (TPVR), and pulmonary balloon angioplasty (PBA) for chronic thromboembolic pulmonary hypertension (CTEPH) have gained significant attention in recent years. As the field continues to evolve, it is essential to examine the long-term outcomes and follow-up of these procedures to ensure their efficacy and safety.

Keywords: Pulmonary valve; Balloon valvuloplasty; Heart valve prosthesis implantation; Angioplasty, balloon

Referanslar

  1. Kan JS, White RI, Mitchell SE, Anderson JH, Gardner TJ. Percutaneous transluminal balloon valvuloplasty for pulmonary valve stenosis. Circulation, 1984;69(3):554-60. [Crossref]  [PubMed]
  2. McCrindle BW. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Circulation, 1994;89(4), 1751-1759. [Crossref]  [PubMed]
  3. Rao PS, Fawzy ME, Solymar L, Mardini MK. Long-term results of balloon pulmonary valvuloplasty of valvar pulmonic stenosis, American Heart Journal, 1988;115(6):1291-1296. [Crossref]  [PubMed]
  4. Chen CR, Cheng TO, Huang T, Zhou LY, Chen JY, Huang YG et al. Percutaneous Balloon Valvuloplasty for Pulmonic Stenosis in Adolescents and Adults, New England Journal of Medicine, 1996;335:21-25 [Crossref]  [PubMed]
  5. Rima R, Munshi AS, Jabbar A, Khan KES. Immediate and Short-Term Results of Balloon Pulmonary Valvuloplasty from Neonates to Grown Up Children with Critical Pulmonary Stenosis: Experience from a Tertiary Care Centre in Bangladesh, Asian Journal of Pediatric ResearchVolume 2023;13(4):104-110. [Crossref]
  6. Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K. Adverse event rates in congenital cardiac catheterization: a multi-center experience. Catheter Cardiovasc Interv. 2010;75:389-400. [Crossref]  [PubMed]
  7. Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM et al. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol 2020;76(24):2847-2858. [Crossref]  [PubMed]
  8. Kaul UA, Singh B, Tyagi S, Bhargava M, Arora R, Khalilullah M. Long-term results after balloon pulmonary valvuloplasty in adults, American Heart Journal, 1993;126(5):1152-5. [Crossref]  [PubMed]
  9. Rao PS, Thapar MK, Kutayli F. Causes of restenosis after balloon valvuloplasty for valvular pulmonary stenosis, American Journal of Cardiology, 1988;62(13):979-82. [Crossref]  [PubMed]
  10. Harrild DM, Powel AJ, Tran TX, Geva T, Lock JE, Rhodes J, et al. Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to exercise capacity and ventricular volume and function, Journal of the American College of Cardiology, 2010;55(10):1041-7 [Crossref]  [PubMed]  [PMC]
  11. Garty Y, Veldtman G, Lee K, Benson L. Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children, The Journal of Invasive Cardiology, 2005;17(6):318-22. [PubMed]
  12. Merino-Ingelmo R, Soto JS, Coserria-Sanchez F, Descalzo-Senoran A, Valverde-Perez I. Long-term results of percutaneous ballon valvuloplasty in pulmonary valve stenosis is the pediatric pupulation; Revista Española de Cardiología (English Edition), 2014; 67(5):374-379 [Crossref]  [PubMed]
  13. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 2000;356(9239):1403-1405. [Crossref]  [PubMed]
  14. Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome, Circulation, 2008;117(15):1964-1972. [Crossref]  [PubMed]
  15. Kenny D, Rhodes JF, Fleming GA, Kar S, Zhan EM, Vincent J et al. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial, JACC Cardiovascular Interventions, 2018;11(19):1920-1929. [Crossref]  [PubMed]
  16. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE et al. Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial, Circulation 2010;122(5):507-516 [Crossref]  [PubMed]  [PMC]
  17. Jones TK, McElhinney DB, Vincent JA, Hellenbrand WE, Cheatham JP, Berman DP et al Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial, Circulation, Cardiovascular Interventions. 2021;15(1):e010852. [Crossref]  [PubMed]  [PMC]
  18. Wilson WM, Benson LN, Osten MD, Shah A, Horlick EM. Transcatheter Pulmonary Valve Replacement With the Edwards Sapien System: The Toronto Experience, Journal of American College of Cardiology, 2015;8(14):1819-27. [Crossref]  [PubMed]
  19. McElhinney DB, Zhang Y, Levi DS, Georgiev S, Biernacka EK, Goldstein BH et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement, Journal of American College of Cardiology, 2022;79(1):18-32. [Crossref]  [PubMed]
  20. Armstrong AK, Balzer DT, Cabalka AK, Gray RG, Javois AJ, Moore JW et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study, JACC Cardiovascular Interventions, 2014;7(11):1254-62. [Crossref]  [PubMed]
  21. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial, Circulation, Cardiovascular Interventions, 2011;4(6):602-14. [Crossref]  [PubMed]
  22. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation, Circulation, 2007;115(11):1392-7. [Crossref]  [PubMed]
  23. Hascoët S, Bentham JR, Giugno L, Betrián-Blasco P, Kempny A, Houeijeh A, et al. Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry, European Heart Journal, 2024;45(3):198210, [Crossref]  [PubMed]
  24. McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM, et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement, Journal of American College of Cardiology, 2021;78(6):575- 589. [Crossref]  [PubMed]
  25. Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons, Journal of the American Society of Echocardiography, 2018;31(4):381-404. [Crossref]  [PubMed]
  26. Holzer RJ, Bergersen L, Thomson J, Aboulhosn J, Aggarwal V, Akagi T et al. PICS/AEPC/APPCS/CSANZ/SCAI/SOLACI: Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Disease, JACC Cardiovascular Interventions, 2024;17(2):115-216. [Crossref]  [PubMed]
  27. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension, Circulation, 2001;103(1):10-3. [Crossref]  [PubMed]
  28. Lang IM, Andreassen AK, Andersen A, Bouvaist H, Coghlan G, Escribano-Subias P, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function, European Heart Journal, 2023;44(29):2659-2671. [Crossref]  [PubMed]  [PMC]
  29. Darocha S, Roik M, Kopec G, Araszkiewicz A, Furdal M, Lewandowski M, et al. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry, EuroIntervention, 2022;17(13):1104-1111. [Crossref]  [PubMed]  [PMC]
  30. Sakamoto H, Goda A, Tobita K, Takeuchi K, Kikuchi H, Inami T et al. EmPHasis-10 Health-Related Quality of Life and Exercise Capacity in Chronic Thromboembolic Pulmonary Hypertension After Balloon Angioplasty, Journal of the American Heart Association, 2022;11(17):e026400. [Crossref]  [PubMed]  [PMC]
  31. Kataoka M, Inami T, Hayashida K, Shimura N, Ushiguro H, Abe T et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension, Circulation, Cardiovascular Interventions, 2012;5(6):756-62. [Crossref]  [PubMed]
  32. Ogawa A, Satoh T, Fukuda T, Sugimura K, Fukumoto Y, Emoto N et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry, Circulation, Cardiovascular Quality and Outcomes, 2017;10(11):e004029. [Crossref]  [PubMed]
  33. Tabuchi I, Ogawa A, Shigetoshi M, Shimokawahara H, Ito H, Matsubara H. Low incidence of restenosis after successful balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Cardiovascular Intervention and Therapeutics, 2023;38(2):231-240. [Crossref]  [PubMed]
  34. Kataoka M, Inami T, Kawakami T, Fukuda K, Satoh T. Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective, JACC, Cardiac Interventions, 2019;12(14):1382-1388. [Crossref]  [PubMed]
  35. Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, et al. ERS statement on chronic thromboembolic pulmonary hypertension, The European Respiratory Journal, 2021;57(6):2002828 [Crossref]  [PubMed]
  36. Fernandes TM, Poch DS, Auger WR. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty, Methodist Debakey Cardiovascular Journal, 2016;12(4):205-212. [Crossref]  [PubMed]  [PMC]